Yıl: 2020 Cilt: 10 Sayı: 4 Sayfa Aralığı: 642 - 649 Metin Dili: İngilizce DOI: 10.31832/smj.791258 İndeks Tarihi: 06-10-2021

Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women

Öz:
Objective There is a role of inflammatory processes on the pathophysiology of rheumatic heart valve disease (RHVD). The neutrophil-lymphocyte ratio (NLR) as an inflammatorymarker is associated with some clinical situations in pregnancy. In this study, we aimed to investigate the predictive role of NLR in pregnant women with NLR.Materials and MethodsFirst-trimester pregnant women, who were referred to cardiology outpatient clinic and diagnosed with RHVD (n=24) were enrolled in this study and age-matched healthypregnant women (n=24) were taken as control groups. The two groups were compared in terms of clinical characteristics, echocardiographic findings, and NLR. The roleof NLO in predicting RKKH has been examined.Results Groups were similar in terms of demographic features. NLR was higher in pregnant women with RHVD than the control group (3.68 ±1.74 vs. 2.68±1.14, p=0.00239). NLR(OR: 0,597, p= 0,037, 95% CI: 0,343-0,921) and neutrophil count (OR: 0,609, p= 0.013, 95% CI: 0,390-0,863) were possible independent predictors of RHVD.Conclusion NLR was significantly higher among pregnant women with RHVD. As it is not possible to provide routine cardiac check-up to all pregnant women; markers for specificrisk groups need to be defined to reduce the risks associated with heart diseases during pregnancy. According to these findings, pregnant women with high NLR may needextra attention in terms of CVD like RHVD. Further studies with large patient groups are needed to define the predictive value of NLR.
Anahtar Kelime:

Nötrofil-Lenfosit Oranının Hamile Kadınlarda Romatizmal Kalp Kapağı Hastalığını Öngörme Yeteneği

Öz:
Amaç Enflamatuar süreçlerin, romatizmal kalp kapağı hastalığı (RKKH) patofizyolojisi üzerinde bir rolü vardır. Enflamatuar bir belirteç olarak nötrofil-lenfosit oranı (NLO), gebelikte bazı klinik durumlarla ilişkilidir. Bu çalışmada, RKKH’li gebelerde NLO’nun prediktif rolünü araştırmayı amaçladık. Gereç ve Yöntemler Çalışmaya kardiyoloji polikliniğine sevk edilen ve RKKH tanısı alan (n = 24) birinci trimester gebeler alındı ve kontrol grubu olarak yaşları eşleşen sağlıklı gebeler (n = 24) alındı. İki grup klinik özellikler, ekokardiyografik bulgular ve NLO açısından karşılaştırıldı. NLO’nun RKKH’nı ön görmedeki rolü incelendi. Bulgular Gruplar demografik özellikler açısından benzerdi. NLO RKKH’lı kadınlarda kontrol grubuna göre daha yüksekti (3.68 ± 1.74 ve 2.68 ± 1.14, p = 0.00239). NLO (OR: 0,597, p= 0,037, 95% CI: 0,343-0,921) ve nötrofil sayısı (OR: 0,609, p= 0.013, 95% CI: 0,390-0,863) RKKH’nın olası bağımsız prediktörleriydi. Sonuç NLO RKKH olan gebe kadınlarda anlamlı olarak daha yüksekti. Tüm hamile kadınlara rutin kardiyak muayene sağlamak mümkün olmadığından; hamilelik sırasında kalp hastalıkları ile ilişkili riskleri azaltmak için spesifik risk grupları için belirteçlerin tanımlanması gerekir. Bu bulgulara göre, yüksek NLO’lı gebe kadınların RKKH gibi KVH açısından daha fazla dikkat göstermeleri gerekebilir. NLO’nın prediktif değerini tanımlamak için geniş hasta gruplarıyla daha ileri çalışmalara ihtiyaç vardır.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Rezk M, Gamal A. Maternal and fetal outcome in women with rheumatic heart disease: a 3-year observational study. Archives of gynecology and obstetrics 2016; 294 (2):273-278.
  • 2. Baysal E, Burak C, Cay S, Aksu T, Altintas B, Yaylak B, et al. Th e neutrophil to lymphocyte ratio is associated with severity of rheumatic mitral valve stenosis. Journal of blood medicine 6:151-156.
  • 3. Olsson M, Th yberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arteriosclerosis, thrombosis, and vascular biology 1999; 19 (5):1218-1222
  • 4. Çiçek, G., Yayla, Ç., Açıkgoz, S. K. Predictive Value of Combination of NLR and PLR in the Absence of Medical Treatment. Angiology 2016; 67(2), 197–197.
  • 5. Yayla, Ç., Karanfil, M., Ertem, A. G., Açar, B., Unal, S., Akboğa, M. K. Infl ammation Parameters in Aortic Aneurysm. Angiology 2019; 70(3), 280–280.
  • 6. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Saff ord M,et al. Women’s Health Initiative Research G Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Archives of internal medicine 2005; 165 (5):500-508.
  • 7. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation aft er coronary artery bypass graft ing. Th e American journal of cardiology 2010; 105 (2):186-191.
  • 8. Golbasi Z, Ucar O, Keles T, Sahin A, Cagli K, Camsari A, et al. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing infl ammation. European journal of heart failure2002; 4 (5):593-595.
  • 9. Kurt RK, Aras Z, Silfeler DB, Kunt C, Islimye M, Kosar O. Relationship of red cell distribution width with the presence and severity of preeclampsia. Clinical and applied thrombosis/ hemostasis : off icial journal of the International Academy of Clinical and Applied Th rombosis/Hemostasis 2015; 21 (2):128-131.
  • 10. Oylumlu M, Ozler A, Yildiz A, Oylumlu M, Acet H, Polat N, et al. New infl ammatory markers in pre-eclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio. Clinical and experimental hypertension 2014; 36 (7):503-507.
  • 11. Yilmaz H, Celik HT, Namuslu M, Inan O, Onaran Y, Karakurt F, et al. Benefits of the neutrophil-to-lymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women. Experimental and clinical endocrinology & diabetes : off icial journal, German Society of Endocrinology [and] German Diabetes Association 2014; 122 (1):39-43.
  • 12. Caglayan EK, Engin-Ustun Y, Gocmen AY, Sari N, Seckin L, Kara M, et al. Is there any relationship between serum sirtuin-1 level and neutrophil-lymphocyte ratio in hyperemesis gravidarum? Journal of perinatal medicine 2016; 44 (3):315-320.
  • 13. Yıldız Ç, Karakuş S, Akkar ÖB, Topbaş T, Çetin M, Yanık A, et al. Th e Significance of Neutrophil-Lymphocyte Ratio and Mean Corpuscular Volume in Diagnosis of Preeclampsia. Gynecol Obstet Reprod Med 2016; 22 (2):75-79.
  • 14. Zuhlke LJ, Beaton A, Engel ME, Hugo-Hamman CT, Karthikeyan G, Katzenellenbogen JM, et al. Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations. Current treatment options in cardiovascular medicine 2017; 19 (2):15.
  • 15. Remenyi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nature reviews Cardiology 2012; 9(5):297-309.
  • 16. ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease. Obstetrics and gynecology 2019; 133 (5):e320-e356.
  • 17. Seeland U, Bauersachs J, Roos-Hesselink J, Regitz-Zagrosek V. [Update of the ESC guidelines 2018 on cardiovascular diseases during pregnancy : Most important facts]. Herz 2018; 43(8):710-718.
  • 18. van Hagen IM, Th orne SA, Taha N, Youssef G, Elnagar A, Gabriel H, et al. Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease. Circulation 2018; 137(8):806-816.
  • 19. Hameed AB, Lawton ES, McCain CL, Morton CH, Mitchell C, Main EK, et al. Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. American journal of obstetrics and gynecology 2015; 213 (3):379 e371-310.
  • 20. Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). European heart journal 2019.
  • 21. Davutoglu V, Celik A, Aksoy M. Contribution of selected serum infl ammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. Th e Journal of heart valve disease 2005; 14 (2):251-256
  • 22. Song J, Zheng Q, Ma X, Zhang Q, Xu Z, Zou C, et al. Predictive Roles of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein in Patients with Calcific Aortic Valve Disease. International heart journal 2019; 60 (2):345-351.
  • 23. Kucukseymen S CG, Guven R, Arslan S. Is neutrophyl to lymphocyte ratio really a useful marker for all grades of degenerative aortic stenosis? Turk Kardiyoloji Dernegi arsivi 2017; 25 (6):506-513
  • 24. Varol E, Aksoy F, Ozaydin M, Erdogan D, Dogan A. Association between neutrophil-lymphocyte ratio and mitral annular calcification. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2014; 25 (6):557-560.
  • 25. Avci A, Elnur A, Goksel A, Serdar F, Servet I, Atilla K, et al. Th e relationship between neutrophil/lymphocyte ratio and calcific aortic stenosis. Echocardiography 2014; 31 (9):1031- 1035.
  • 26. Akboga MK, Akyel A, Sahinarslan A, Yayla C, Alsancak Y, Gokalp G, et al. Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis? Anatolian journal of cardiology 2015; 15 (5):380-384.
APA BOZKAYA V, Oskovi Kaplan Z, Engin-Ustun Y (2020). Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. , 642 - 649. 10.31832/smj.791258
Chicago BOZKAYA VECİHA ÖZLEM,Oskovi Kaplan Zeynep Aslı,Engin-Ustun Yaprak Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. (2020): 642 - 649. 10.31832/smj.791258
MLA BOZKAYA VECİHA ÖZLEM,Oskovi Kaplan Zeynep Aslı,Engin-Ustun Yaprak Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. , 2020, ss.642 - 649. 10.31832/smj.791258
AMA BOZKAYA V,Oskovi Kaplan Z,Engin-Ustun Y Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. . 2020; 642 - 649. 10.31832/smj.791258
Vancouver BOZKAYA V,Oskovi Kaplan Z,Engin-Ustun Y Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. . 2020; 642 - 649. 10.31832/smj.791258
IEEE BOZKAYA V,Oskovi Kaplan Z,Engin-Ustun Y "Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women." , ss.642 - 649, 2020. 10.31832/smj.791258
ISNAD BOZKAYA, VECİHA ÖZLEM vd. "Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women". (2020), 642-649. https://doi.org/10.31832/smj.791258
APA BOZKAYA V, Oskovi Kaplan Z, Engin-Ustun Y (2020). Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. Sakarya Tıp Dergisi, 10(4), 642 - 649. 10.31832/smj.791258
Chicago BOZKAYA VECİHA ÖZLEM,Oskovi Kaplan Zeynep Aslı,Engin-Ustun Yaprak Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. Sakarya Tıp Dergisi 10, no.4 (2020): 642 - 649. 10.31832/smj.791258
MLA BOZKAYA VECİHA ÖZLEM,Oskovi Kaplan Zeynep Aslı,Engin-Ustun Yaprak Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. Sakarya Tıp Dergisi, vol.10, no.4, 2020, ss.642 - 649. 10.31832/smj.791258
AMA BOZKAYA V,Oskovi Kaplan Z,Engin-Ustun Y Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. Sakarya Tıp Dergisi. 2020; 10(4): 642 - 649. 10.31832/smj.791258
Vancouver BOZKAYA V,Oskovi Kaplan Z,Engin-Ustun Y Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women. Sakarya Tıp Dergisi. 2020; 10(4): 642 - 649. 10.31832/smj.791258
IEEE BOZKAYA V,Oskovi Kaplan Z,Engin-Ustun Y "Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women." Sakarya Tıp Dergisi, 10, ss.642 - 649, 2020. 10.31832/smj.791258
ISNAD BOZKAYA, VECİHA ÖZLEM vd. "Capibility of Neuthrophil-lymphocyte Ratio to Predict Rheumatic Heart Valve Disease In Pregnant Women". Sakarya Tıp Dergisi 10/4 (2020), 642-649. https://doi.org/10.31832/smj.791258